Biopharma & Life Sciences

Phibro Animal Health Executive Compensation (FY26)

Name: Phibro Animal Health (PAHC) executive compensation
Creator: Velarion
License: https://intel.velarion.ai/terms

PAHC · Executive and director compensation, fiscal 2022 to 2026

Chief executive, fiscal 2026

◇

Daniel Bendheim

Latest say-on-pay support

November 4, 2025

Chief executive pay ratio

◇

To the median employee

Free for 3 days · no card

See how Phibro Animal Health’s pay stands against its peers

Phibro Animal Health's company dashboard and its AI-written, board-ready brief, every figure cited to the filing
Peer-group intelligence, custom peer reruns and governance screens
Every other company we cover, with alerts when they file

Start my free trial on PAHC See the plan and pricing

No card. Nothing is charged, and the trial ends on its own. After the trial: $499/month, or $5,000/year, about two months free.

Velarion Intel, $499/month, or $5,000/year, about two months free: one seat · every company we cover, with dashboards, peer screens and board-ready briefs.

The Phibro Animal Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

From $500 for the board report; $900 for both.

Get the executive brief Get the board briefNo account needed.

Data as of November 10, 2026Latest filing (DEF 14A): September 18, 2026

6 filings cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Phibro Animal Health brief$500Get the executive brief

Velarion Intel, one year, every company

191 figures on this page: 188 cited to the filing that reported them, 3 calculated from figures it prints. See the citations

What changed from fiscal 2025 to fiscal 2026

The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.

Chief executive total compensation — Daniel Bendheim: $1,119,780 → $1,120,094 (0.0% higher)

CEO pay ratio: 95:1 → 74:1 (22.1% lower)

Frequently asked questions

Answers drawn from the data on this page.

Who is Phibro Animal Health's chief executive and what were they paid?

Daniel Bendheim was paid $1,120,094 in total compensation as President and Chief Executive Officer for fiscal 2026. Bendheim's total was 0.0% higher than the $1,119,780 reported for fiscal 2025.

What was Phibro Animal Health's say-on-pay result?

Shareholders recorded 99.4% support for the say-on-pay proposal at the meeting held November 4, 2025 for fiscal 2025.

What is Phibro Animal Health's chief executive pay ratio?

For fiscal 2026, the company reported a chief executive pay ratio of 74:1, against median employee compensation of $71,100.

Executive compensation

Every element reported for each named executive officer, by fiscal year.

Fiscal 2022

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Jack Bendheim Chairman of the Board, President, and Chief Executive Officer	◇	—	—	—	◇	◇	◇	◇
Larry Miller Chief Operating Officer	◇	—	—	—	◇	—	◇	◇
Rob Aukerman President, North America Region	◇	◇	—	—	◇	—	◇	◇
Damian Finio Chief Financial Officer	◇	—	—	—	◇	—	◇	◇
Daniel Bendheim Director and Executive Vice President, Corporate Strategy	◇	—	—	—	◇	—	◇	◇

Fiscal 2023

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Jack Bendheim Chairman of the Board, President, and Chief Executive Officer	◇	—	—	—	◇	◇	◇	◇
Larry Miller Chief Operating Officer	◇	—	—	—	◇	◇	◇	◇
Rob Aukerman President, North America Region	◇	◇	—	—	◇	—	◇	◇
Damian Finio Chief Financial Officer	◇	—	—	—	◇	—	◇	◇
Daniel Bendheim Director and Executive Vice President, Corporate Strategy	◇	—	—	—	◇	◇	◇	◇

Fiscal 2024

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Jack Bendheim President and Chief Executive Officer	◇	◇	—	—	◇	◇	◇	◇
Larry Miller Chief Operating Officer	◇	◇	◇	—	◇	◇	◇	◇
Glenn David Chief Financial Officer	◇	◇	◇	—	—	—	◇	◇
Daniel Bendheim President and Chief Executive Officer	◇	◇	—	—	◇	—	◇	◇

Fiscal 2025

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Jack Bendheim Chairman of the Board and Executive Chairman	◇	◇	—	—	◇	◇	◇	◇
Larry Miller Chief Operating Officer	◇	◇	—	—	◇	◇	◇	◇
Glenn David Chief Financial Officer	◇	◇	—	—	◇	—	◇	◇
Daniel Bendheim President and Chief Executive Officer	◇	◇	—	—	◇	◇	◇	◇
Judith Weinstein Senior Vice President, General Counsel and Corporate Secretary	◇	◇	—	—	◇	◇	◇	◇

Fiscal 2026

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Jack Bendheim Chairman of the Board and Executive Chairman	◇	—	◇	—	◇	◇	◇	◇
Larry Miller Chief Operating Officer	◇	◇	◇	—	◇	◇	◇	◇
Glenn David Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇
Daniel Bendheim President and Chief Executive Officer	◇	—	◇	—	◇	◇	◇	◇
Judith Weinstein Senior Vice President, General Counsel and Corporate Secretary	◇	—	◇	—	◇	◇	◇	◇

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.

Fiscal 2026

Officer	Award	Grant date	Threshold units	Target units	Units granted	Maximum units	Exercise price	Grant date fair value
Daniel M. Bendheim	RSU	◇	—	—	◇	—	—	◇
Glenn David	RSU	◇	—	—	◇	—	—	◇
Jack C. Bendheim	RSU	◇	—	—	◇	—	—	◇
Judith Weinstein	RSU	◇	—	—	◇	—	—	◇
Larry L. Miller	RSU	◇	—	—	◇	—	—	◇

Fiscal 2025 are included in the PDF.

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.

As disclosed at fiscal 2026 year end

Officer	Award	Unvested units	Market value of unvested units	Exercise price	Expires
Larry Miller	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
Glenn David	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Jack Bendheim	RSU	◇	◇	—	—
Daniel Bendheim	RSU	◇	◇	—	—
Judith Weinstein	RSU	◇	◇	—	—

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.

Judith Weinstein

Senior Vice President, General Counsel and Corporate Secretary · Severance agreement

Severance multiple

◇

Larry Miller

Chief Operating Officer · Employment agreement

Severance multiple

◇

Director compensation

What each non-employee director was paid.

Fiscal 2026

Director	Fees earned in cash	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Carol A. Wrenn	◇	—	—	—	—	—	◇
Sam Gejdenson	◇	—	—	—	—	—	◇
E. Thomas Corcoran	◇	—	—	—	—	—	◇
Alejandro Bernal	◇	—	—	—	—	—	◇
Mary Lou Malanoski	◇	—	—	—	—	—	◇
Joyce J. Lee	◇	—	—	—	—	—	◇

Daniel M. Bendheim and Jack C. Bendheim served on the board in fiscal 2026 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.

Earlier years are included in the PDF.

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.

Board cash retainer	◇
Audit committee member	◇
Compensation committee member	◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Say-on-pay history

Shareholder support for the compensation program, by year.

Year	Meeting	Support	Votes for	Votes against	Abstentions
2025	November 4, 2025	=	◇	◇	◇
2022	November 7, 2022	=	◇	◇	◇
2019	November 4, 2019	=	◇	◇	◇

Chief executive pay ratio

As calculated and reported by the company.

Ratio

◇

Median employee compensation

◇

Chief executive total compensation

◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”

- Daniel Bendheim (President and Chief Executive Officer), FY2026 total compensation $1,120,094 (base salary $575,000) [exec_comp, SEC accession 0001104659-26-108939, filed 2026-09-18]

See a complete sample report

What this page does not include

Everything above is a fact Phibro Animal Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.

Written compensation analysis

A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.

Executive Compensation Report — $500

Board and governance analysis

Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.

Board Governance Report — $500

Realizable pay

What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.

Velarion Intelligence

Adviser switching and vote outcomes

Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.

Inquire about access

Multiple companies at once

Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.

Velarion Intelligence

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.

191 figures on this page: 188 cited to the filing that reported them, 3 calculated from figures it prints.

188 cited to the filing

3 calculated from the filing

Documents cited

DEF 14A, filed September 18, 2026
0001104659-26-108939
2026 Director Compensation · 2026 Summary Compensation Table · CEO PAY RATIO · Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards in Fiscal Year 2026 · and 1 more section
8-K, filed November 5, 2025
0001104659-25-107064
DEF 14A, filed September 19, 2025
0001104659-25-091650
2025 Summary Compensation Table
DEF 14A, filed September 15, 2023
0001558370-23-015820
2023 Summary Compensation Table
8-K, filed November 8, 2022
0001104659-22-115975
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
8-K, filed November 5, 2019
0001104659-19-060110

Cite this data

This page is free to cite. Attribution we ask for:

Velarion, “Phibro Animal Health executive compensation, FY2022–FY2026.” https://intel.velarion.ai/comp/PAHC (accessed 2026).

Short form: data: Velarion

The Phibro Animal Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

From $500 for the board report; $900 for both.

Get the executive brief Get the board briefNo account needed.

6 filings cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Embed this data

A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.

The headline figures, each with its citation.

<iframe src="https://intel.velarion.ai/comp/PAHC/embed" width="560" height="480" style="border:1px solid #d8dee8;border-radius:10px" loading="lazy" title="Phibro Animal Health executive compensation, from Velarion"></iframe>

Connect an AI assistant

Ask your own assistant about Phibro Animal Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

{
  "mcpServers": {
    "velarion": {
      "type": "http",
      "url": "https://api.velarion.ai/mcp"
    }
  }
}

Setup guide and the full list of questions it answers

Biopharma & Life Sciences rankings

Chief executive pay — Biopharma & Life Sciences CEO pay ratio — Biopharma & Life Sciences Say-on-pay support — Biopharma & Life Sciences

Terms on this page

Say-on-Pay Vote CEO Pay Ratio Median Employee Compensation All companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data

APA

Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854

BibTeX

@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}